TABLE OF CONTENTS
Volume 29, Issue 1 (January 2004)
Original Articles
Alterations in Central Neuropeptide Expression, Release, and Receptor Binding in Rats Bred for High Anxiety: Critical Role of Vasopressin FREE
Alexandra Wigger, Mar M Sánchez, Kenneth C Mathys, Karl Ebner, Elisabeth Frank, Dong Liu, Adelheid Kresse, Inga D Neumann, Florian Holsboer, Paul M Plotsky and Rainer Landgraf
Neuropsychopharmacology 29: 1-14; advance online publication, August 27, 2003; doi:10.1038/sj.npp.1300290
Corticotropin-Releasing Hormone (CRH) mRNA Expression in Rat Central Amygdala in Cannabinoid Tolerance and Withdrawal: Evidence for an Allostatic Shift? FREE
Laura Caberlotto, Roberto Rimondini, Anita Hansson, Siv Eriksson and Markus Heilig
Neuropsychopharmacology 29: 15-22; advance online publication, September 10, 2003; doi:10.1038/sj.npp.1300296
Downregulation of the CCAAT-Enhancer Binding Protein
in
FosB Transgenic Mice and by Electroconvulsive Seizures FREE
Jingshan Chen, Samuel S Newton, Ling Zeng, David H Adams, Anthoni L Dow, Torsten M Madsen, Eric J Nestler and Ronald S Duman
Neuropsychopharmacology 29: 23-31; advance online publication, October 8, 2003; doi:10.1038/sj.npp.1300289
In Vivo Evidence in the Brain for Lithium Inhibition of Glycogen Synthase Kinase-3 FREE
Todd D Gould, Guang Chen and Husseini K Manji
Neuropsychopharmacology 29: 32-38; advance online publication, August 27, 2003; doi:10.1038/sj.npp.1300283
Convergent Effects of Lithium and Valproate on the Expression of Proteins Associated with Large Dense Core Vesicles in NGF-differentiated PC12 Cells FREE
Mara L Cordeiro, Cameron B Gundersen and Joy A Umbach
Neuropsychopharmacology 29: 39-44; advance online publication, September 3, 2003; doi:10.1038/sj.npp.1300288
Stress Impairs
1A Adrenoceptor-Mediated Noradrenergic Facilitation of GABAergic Transmission in the Basolateral Amygdala FREE
Maria Fatima M Braga, Vassiliki Aroniadou-Anderjaska, Sean T Manion, Christopher J Hough and He Li
Neuropsychopharmacology 29: 45-58; advance online publication, October 8, 2003; doi:10.1038/sj.npp.1300297
Nociceptin/Orphanin FQ Increases Anxiety-Related Behavior and Circulating Levels of Corticosterone During Neophobic Tests of Anxiety FREE
Fabian Fernandez, Michael A Misilmeri, Jennifer C Felger and Darragh P Devine
Neuropsychopharmacology 29: 59-71; advance online publication, October 8, 2003; doi:10.1038/sj.npp.1300308
Dopamine in the Medial Prefrontal Cortex Controls Genotype-Dependent Effects of Amphetamine on Mesoaccumbens Dopamine Release and Locomotion FREE
Rossella Ventura, Antonio Alcaro, Simona Cabib, Davide Conversi, Laura Mandolesi and Stefano Puglisi-Allegra
Neuropsychopharmacology 29: 72-80; advance online publication, September 10, 2003; doi:10.1038/sj.npp.1300300
Biological Basis of Sex Differences in the Propensity to Self-administer Cocaine FREE
Ming Hu, Hans S Crombag, Terry E Robinson and Jill B Becker
Neuropsychopharmacology 29: 81-85; advance online publication, September 3, 2003; doi:10.1038/sj.npp.1300301
The
2A-Adrenergic Agonist Guanfacine Improves Visuomotor Associative Learning in Monkeys FREE
Min Wang, Jin-Zhao Ji and Bao-Ming Li
Neuropsychopharmacology 29: 86-92; advance online publication, August 20, 2003; doi:10.1038/sj.npp.1300278
The 5-HT6 Receptor Antagonist SB-271046 Reverses Scopolamine-Disrupted Consolidation of a Passive Avoidance Task and Ameliorates Spatial Task Deficits in Aged Rats FREE
Andrew G Foley, Keith J Murphy, Warren D Hirst, Helen C Gallagher, Jim J Hagan, Neil Upton, Frank S Walsh and Ciaran M Regan
Neuropsychopharmacology 29: 93-100; advance online publication, October 22, 2003; doi:10.1038/sj.npp.1300332
Anxiogenic Effect of Cholecystokinin in the Dorsal Periaqueductal Gray FREE
Cristina Ferreira Netto and Francisco Silveira Guimarães
Neuropsychopharmacology 29: 101-107; advance online publication, October 29, 2003; doi:10.1038/sj.npp.1300334
Nicotinic Acetylcholine Receptor Distribution in Alzheimer's Disease, Dementia with Lewy Bodies, Parkinson's Disease, and Vascular Dementia: In Vitro Binding Study Using 5-[125I]-A-85380 FREE
S L Pimlott, M Piggott, J Owens, E Greally, J A Court, E Jaros, R H Perry, E K Perry and D Wyper
Neuropsychopharmacology 29: 108-116; advance online publication, September 3, 2003; doi:10.1038/sj.npp.1300302
Glutamate Carboxypeptidase II Gene Expression in the Human Frontal and Temporal Lobe in Schizophrenia FREE
Subroto Ghose, Cynthia Shannon Weickert, Sarah M Colvin, Joseph T Coyle, Mary M Herman, Thomas M Hyde and Joel E Kleinman
Neuropsychopharmacology 29: 117-125; advance online publication, October 15, 2003; doi:10.1038/sj.npp.1300304
Differential Expression of Pentraxin 3 in Fibroblasts from Patients with Major Depression FREE
Richard C Shelton, Shan Liang, Peng Liang, Amitabha Chakrabarti, D Hal Manier and Fridolin Sulser
Neuropsychopharmacology 29: 126-132; advance online publication, November 5, 2003; doi:10.1038/sj.npp.1300307
A Pilot Study of Risperidone, Olanzapine, and Haloperidol in Psychotic Youth: A Double-Blind, Randomized, 8-Week Trial FREE
Linmarie Sikich, Robert M Hamer, Robert A Bashford, Brian B Sheitman and Jeffrey A Lieberman
Neuropsychopharmacology 29: 133-145; advance online publication, October 29, 2003; doi:10.1038/sj.npp.1300327
The Somatostatin Analogue Octreotide Impairs Sleep and Decreases EEG Sigma Power in Young Male Subjects FREE
M Ziegenbein, K Held, H E Kuenzel, H Murck, I A Antonijevic and A Steiger
Neuropsychopharmacology 29: 146-151; advance online publication, September 3, 2003; doi:10.1038/sj.npp.1300298
Stress of Dying is not Suppressed by High-dose Morphine or by Dementia FREE
Zeynel A Erkut, Tamira Klooker, Eric Endert, Inge Huitinga and Dick F Swaab
Neuropsychopharmacology 29: 152-157; advance online publication, September 3, 2003; doi:10.1038/sj.npp.1300299
Marijuana Withdrawal in Humans: Effects of Oral THC or Divalproex FREE
Margaret Haney, Carl L Hart, Suzanne K Vosburg, Jennifer Nasser, Andrew Bennett, Carlos Zubaran and Richard W Foltin
Neuropsychopharmacology 29: 158-170; advance online publication, October 15, 2003; doi:10.1038/sj.npp.1300310
Clozapine but not Haloperidol Re-establishes Normal Task-Activated rCBF Patterns in Schizophrenia within the Anterior Cingulate Cortex FREE
Adrienne C Lahti, Henry H Holcomb, Martin A Weiler, Deborah R Medoff, Kristin N Frey, Michael Hardin and Carol A Tamminga
Neuropsychopharmacology 29: 171-178; advance online publication, October 8, 2003; doi:10.1038/sj.npp.1300312
Childhood Inattention and Dysphoria and Adult Obesity Associated with the Dopamine D4 receptor Gene in Overeating Women with Seasonal Affective Disorder FREE
R D Levitan, M Masellis, R W Lam, P Muglia, V S Basile, U Jain, A S Kaplan, S Tharmalingam, S H Kennedy and J L Kennedy
Neuropsychopharmacology 29: 179-186; advance online publication, October 15, 2003; doi:10.1038/sj.npp.1300314
Motor-learning Impairment by Amantadine in Healthy Volunteers FREE
Abdallah Hadj Tahar, Pierre J Blanchet and Julien Doyon
Neuropsychopharmacology 29: 187-194; advance online publication, October 8, 2003; doi:10.1038/sj.npp.1300317
Amphetamine Primes Motivation to Gamble and Gambling-Related Semantic Networks in Problem Gamblers FREE
Martin Zack and Constantine X Poulos
Neuropsychopharmacology 29: 195-207; advance online publication, October 22, 2003; doi:10.1038/sj.npp.1300333
Acute Effects of Ketamine on Memory Systems and Psychotic Symptoms in Healthy Volunteers FREE
Celia J A Morgan, Ali Mofeez, Brigitta Brandner, Lesley Bromley and H Valerie Curran
Neuropsychopharmacology 29: 208-218; advance online publication, November 5, 2003; doi:10.1038/sj.npp.1300342


